Amicus Therapeutics, Inc.FOLDNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
170.87%
↑ 18391% above average
Average (39q)
0.92%
Historical baseline
Range
High:319.04%
Low:-247.13%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 170.87% |
| Q2 2025 | -12.61% |
| Q1 2025 | -247.13% |
| Q4 2024 | 319.04% |
| Q3 2024 | 57.13% |
| Q2 2024 | 67.58% |
| Q1 2024 | -43.07% |
| Q4 2023 | -56.85% |
| Q3 2023 | 50.09% |
| Q2 2023 | 18.33% |
| Q1 2023 | 5.25% |
| Q4 2022 | -67.83% |
| Q3 2022 | 46.45% |
| Q2 2022 | 27.10% |
| Q1 2022 | -2.38% |
| Q4 2021 | -65.58% |
| Q3 2021 | 1.82% |
| Q2 2021 | 21.99% |
| Q1 2021 | 8.03% |
| Q4 2020 | -11.54% |
| Q3 2020 | -21.94% |
| Q2 2020 | 40.99% |
| Q1 2020 | 0.87% |
| Q4 2019 | -45.17% |
| Q3 2019 | 26.90% |
| Q2 2019 | 29.72% |
| Q1 2019 | -54.07% |
| Q4 2018 | 50.94% |
| Q3 2018 | -157.41% |
| Q2 2018 | -23.87% |
| Q1 2018 | 27.88% |
| Q4 2017 | 38.02% |
| Q3 2017 | -131.98% |
| Q2 2017 | 12.47% |
| Q1 2017 | 6.23% |
| Q4 2016 | -25.71% |
| Q3 2016 | 8.61% |
| Q2 2016 | -16.84% |
| Q1 2016 | -1.85% |
| Q4 2015 | -13.48% |